Cargando…

B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa

BACKGROUND: Despite antiretroviral treatment (ART), immune dysfunction persists in children with perinatal HIV infection (HEI). Here we investigated the impact of HIV status on maternal antibody (Ab) passage, long-term vaccine induced immunity and B-cell maturation. METHODS: 46 HIV Exposed Uninfecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotugno, Nicola, Pallikkuth, Suresh, Sanna, Marco, Dinh, Vinh, de Armas, Lesley, Rinaldi, Stefano, Davis, Sheldon, Linardos, Giulia, Pascucci, Giuseppe Rubens, Pahwa, Rajendra, Sitoe, Nadia, Vaz, Paula, Rossi, Paolo, Lain, Maria Grazia, Palma, Paolo, Pahwa, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363429/
https://www.ncbi.nlm.nih.gov/pubmed/37406590
http://dx.doi.org/10.1016/j.ebiom.2023.104666
_version_ 1785076623130755072
author Cotugno, Nicola
Pallikkuth, Suresh
Sanna, Marco
Dinh, Vinh
de Armas, Lesley
Rinaldi, Stefano
Davis, Sheldon
Linardos, Giulia
Pascucci, Giuseppe Rubens
Pahwa, Rajendra
Sitoe, Nadia
Vaz, Paula
Rossi, Paolo
Lain, Maria Grazia
Palma, Paolo
Pahwa, Savita
author_facet Cotugno, Nicola
Pallikkuth, Suresh
Sanna, Marco
Dinh, Vinh
de Armas, Lesley
Rinaldi, Stefano
Davis, Sheldon
Linardos, Giulia
Pascucci, Giuseppe Rubens
Pahwa, Rajendra
Sitoe, Nadia
Vaz, Paula
Rossi, Paolo
Lain, Maria Grazia
Palma, Paolo
Pahwa, Savita
author_sort Cotugno, Nicola
collection PubMed
description BACKGROUND: Despite antiretroviral treatment (ART), immune dysfunction persists in children with perinatal HIV infection (HEI). Here we investigated the impact of HIV status on maternal antibody (Ab) passage, long-term vaccine induced immunity and B-cell maturation. METHODS: 46 HIV Exposed Uninfected (HEU), 43 HEI, and 15 HIV unexposed uninfected (HUU) infants were vaccinated with 3 doses of DTaP-HepB-Hib-PCV10-OP at 2, 3, and 4 months at Matola Provincial Hospital, Maputo, Mozambique. Tetanus toxoid specific (TT) IgG, HIV Ab and B-cell phenotype characteristics were evaluated at entry, pre-ART, 5, 10, and 18 months in this longitudinal cohort study. FINDINGS: Baseline (maternal) plasma TT Ab levels were significantly lower in HEI compared to both HEU and HUU and a faster decay of TT Ab was observed in HEI compared to HEU with significantly lower TT Ab levels at 10 and 18 months of age. TT unprotected (UP) (≤0.1 IU/mL) HEI showed higher HIV-RNA at entry and higher longitudinal HIV viremia (Area Under the Curve) compared to TT protected (P) HEI. A distinct HIV-Ab profile was found at entry in HEI compared to HEU. B-cell phenotype showed a B-cell perturbation in HEI vs HEU infants at entry (mean age 40.8 days) with lower transitional CD10+CD19+ B-cells and IgD+CD27− naive B-cells and an overall higher frequency of IgD−CD27− double negative B-cell subsets in HEI. INTERPRETATION: B-cell perturbation, presenting with higher double negative IgD−CD27− B-cells was observed in neonatal age and may play a major role in the B-cell exhaustion in HEI. The ability to maintain TT protective Ab titers over time is impaired in HEI with uncontrolled viral replication and the current vaccination schedule is insufficient to provide long-term protection against tetanus. FUNDING: This work was supported by: 10.13039/100000002NIH grant to SP (5R01AI127347-05); Children’s Hospital Bambino Gesú (Ricerca corrente 2019) to NC, and Associazione Volontari Bambino Gesù to PP.
format Online
Article
Text
id pubmed-10363429
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103634292023-07-25 B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa Cotugno, Nicola Pallikkuth, Suresh Sanna, Marco Dinh, Vinh de Armas, Lesley Rinaldi, Stefano Davis, Sheldon Linardos, Giulia Pascucci, Giuseppe Rubens Pahwa, Rajendra Sitoe, Nadia Vaz, Paula Rossi, Paolo Lain, Maria Grazia Palma, Paolo Pahwa, Savita eBioMedicine Articles BACKGROUND: Despite antiretroviral treatment (ART), immune dysfunction persists in children with perinatal HIV infection (HEI). Here we investigated the impact of HIV status on maternal antibody (Ab) passage, long-term vaccine induced immunity and B-cell maturation. METHODS: 46 HIV Exposed Uninfected (HEU), 43 HEI, and 15 HIV unexposed uninfected (HUU) infants were vaccinated with 3 doses of DTaP-HepB-Hib-PCV10-OP at 2, 3, and 4 months at Matola Provincial Hospital, Maputo, Mozambique. Tetanus toxoid specific (TT) IgG, HIV Ab and B-cell phenotype characteristics were evaluated at entry, pre-ART, 5, 10, and 18 months in this longitudinal cohort study. FINDINGS: Baseline (maternal) plasma TT Ab levels were significantly lower in HEI compared to both HEU and HUU and a faster decay of TT Ab was observed in HEI compared to HEU with significantly lower TT Ab levels at 10 and 18 months of age. TT unprotected (UP) (≤0.1 IU/mL) HEI showed higher HIV-RNA at entry and higher longitudinal HIV viremia (Area Under the Curve) compared to TT protected (P) HEI. A distinct HIV-Ab profile was found at entry in HEI compared to HEU. B-cell phenotype showed a B-cell perturbation in HEI vs HEU infants at entry (mean age 40.8 days) with lower transitional CD10+CD19+ B-cells and IgD+CD27− naive B-cells and an overall higher frequency of IgD−CD27− double negative B-cell subsets in HEI. INTERPRETATION: B-cell perturbation, presenting with higher double negative IgD−CD27− B-cells was observed in neonatal age and may play a major role in the B-cell exhaustion in HEI. The ability to maintain TT protective Ab titers over time is impaired in HEI with uncontrolled viral replication and the current vaccination schedule is insufficient to provide long-term protection against tetanus. FUNDING: This work was supported by: 10.13039/100000002NIH grant to SP (5R01AI127347-05); Children’s Hospital Bambino Gesú (Ricerca corrente 2019) to NC, and Associazione Volontari Bambino Gesù to PP. Elsevier 2023-07-03 /pmc/articles/PMC10363429/ /pubmed/37406590 http://dx.doi.org/10.1016/j.ebiom.2023.104666 Text en © 2023 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Cotugno, Nicola
Pallikkuth, Suresh
Sanna, Marco
Dinh, Vinh
de Armas, Lesley
Rinaldi, Stefano
Davis, Sheldon
Linardos, Giulia
Pascucci, Giuseppe Rubens
Pahwa, Rajendra
Sitoe, Nadia
Vaz, Paula
Rossi, Paolo
Lain, Maria Grazia
Palma, Paolo
Pahwa, Savita
B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title_full B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title_fullStr B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title_full_unstemmed B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title_short B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa
title_sort b-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal hiv-infection in mozambique, africa
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363429/
https://www.ncbi.nlm.nih.gov/pubmed/37406590
http://dx.doi.org/10.1016/j.ebiom.2023.104666
work_keys_str_mv AT cotugnonicola bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT pallikkuthsuresh bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT sannamarco bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT dinhvinh bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT dearmaslesley bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT rinaldistefano bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT davissheldon bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT linardosgiulia bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT pascuccigiusepperubens bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT pahwarajendra bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT sitoenadia bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT vazpaula bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT rossipaolo bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT lainmariagrazia bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT palmapaolo bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica
AT pahwasavita bcellimmunityandvaccineinducedantibodyprotectionrevealtheinefficacyofcurrentvaccinationscheduleininfantswithperinatalhivinfectioninmozambiqueafrica